Hevea-latex

Main information

  • Trade name:
  • Hevea-latex examination/treatment glove, non-powdered, sterile
  • Class:
  • Class Is
  • Medicine domain:
  • Humans
  • Medicine type:
  • Medical device

Documents

Localization

  • Available in:
  • Hevea-latex examination/treatment glove, non-powdered, sterile
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 217562
  • Last update:
  • 09-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

217562

Medline International Two Australia Pty Ltd - Hevea-latex examination/treatment glove, non-powdered,

sterile

ARTG entry for

Medical Device Included Class Is

Sponsor

Medline International Two Australia Pty Ltd

Postal Address

PO Box 4366,MARAYONG, NSW, 2148

Australia

ARTG Start Date

20/11/2013

Product category

Medical Device Class Is

Status

Active

Approval area

Medical Devices

Conditions

- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,

Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations

2002 for relevant information.

- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal

offence; and civil penalties may apply.

Manufacturers

Name

Address

Medline Industries Inc

1200 Townline Road One Medline Place

Mundelein, IL, 60060

United States Of America

Products

1. Hevea-latex examination/treatment glove, non-powdered, sterile

Product Type

Single Device Product

Effective date

20/11/2013

GMDN

59096 Hevea-latex examination/treatment glove, non-powdered, sterile

Intended purpose

A single-use sterile device used on the hands of an examiner as a protective barrier between the examiner

and patient.

Specific Conditions

No Specific Conditions included on Record

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 10.11.2017 at 01:53:21 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

19-4-2018

Fluad trivalent influenza vaccine

Fluad trivalent influenza vaccine

Safety advisory - risk to patients with latex allergy

Therapeutic Goods Administration - Australia

15-5-2018

Medicine labels: Guidance on TGO 91 and TGO 92

Medicine labels: Guidance on TGO 91 and TGO 92

The guidance for medicine labels has been updated to improve clarity for sponsors. It also includes new best practice on latex labelling.

Therapeutic Goods Administration - Australia